# 239 - ICH Q12: What’s Binding? Established Conditions and Post-Approval Changes

Page: https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes
Text version: https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes.md
Podcast: [Let's Combinate - Drugs + Devices](https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248)
Published: 2026-05-27T12:24:18+00:00
Episode link: https://podcasters.spotify.com/pod/show/letscombinate/episodes/239---ICH-Q12-Whats-Binding--Established-Conditions-and-Post-Approval-Changes-e3jt5h6
Audio file: https://anchor.fm/s/6770b9a0/podcast/play/120542182/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-26%2F424889402-44100-2-7cb3c15a0de17.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes
Duration seconds: 645

## Resource

In this episode, Subhi breaks down ICH Q12, the guideline focused on post-approval change management and pharmaceutical product lifecycle management. The core question behind ICH Q12 is simple: once a product is approved, what is actually binding, what is supporting information, and how should future changes be managed? This episode covers the major Q12 concepts, including reporting categories, Established Conditions, supporting information, Post-Approval Change Management Protocols, the Product Lifecycle Management document, and the role of the Pharmaceutical Quality System. Subhi also discusses why Q12 matters for drug-device combination products, where lifecycle changes may involve CMC information, device constituent parts, functional performance characteristics, and the broader control strategy. Key topics covered: Why post-approval change can become difficult after approval How ICH Q12 supports more predictable lifecycle management Reporting categories for post-approval CMC changes Established Conditions versus supporting information Examples of EC candidates, including CQAs, CPPs, material attributes, methods, sites, and process information Why overcommitting or undercommitting ECs creates lifecycle risk How PACMPs help companies plan future changes What belongs in the PLCM document How ICH Q12 applies to drug-device combination products Why a strong PQS is essential for making Q12 work Timestamps: 00:00 Introduction to ICH Q12 00:46 Why post-approval change gets difficult 02:45 Reporting categories 03:14 Established Conditions vs supporting information 04:10 EC examples: CQAs, CPPs, methods, sites, and process information 05:32 Post-Approval Change Management Protocols 06:38 PLCM document 08:08 Drug-device combination product callout 10:11 PQS and change managem…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/239-ich-q12-what-s-binding-established-conditions-and-post-approval-changes.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.